Cipralex demonstrates superiority to duloxetine for acute treatment
of depression in new study
COPENHAGEN, June 4, 2007-A new study published today in thejournal Current Medical Research and Opinion showed thatCipralex® (escitalopram) was superior to Cymbalta®(
duloxetine) in the acute treatment of patients with majordepressive disorder (MDD) and was at least as efficacious inlong-term treatment. The study directly compared Cipralex® (anallosteric serotonin reuptake inh...
Newly Published Data Demonstrates Superiority of Cipralex Over
Duloxetine for Acute Treatment of Depression
- Cipralex Better Tolerated and at Least as Effective inLong-Term Treatment H. Lundbeck A/S announces new study data published today in thejournal Current Medical Research and Opinion, demonstrating thatCipralex(R) (escitalopram) was superior to
duloxetine in the acutetreatment of patients with major depressive disorder (MDD)...
In New Study, Duloxetine Was Equally Effective, Regardless of
Switch Method, in Reducing Painful Symptoms in Ssri Non- or
Partial-responders with Depression
SAN DIEGO, California, 23 May 2007 - The antidepressant
duloxetinehydrochloride was equally effective in reducing painful symptoms indepressed patients who did not respond, or responded onlypartially, to treatment with a selective serotonin reuptakeinhibitor (SSRI), regardless of whether those patients wereswitched from an SSRI abruptly or gradually. This newdata was presented t...
In New Study, Duloxetine Reduced Non-specific Pain and Emotional
Symptoms Associated with Depression
MADRID, Spain, 19 march 2007 - The antidepressant
duloxetine, ata once-daily dose of 60 mg, significantly reduced non-specific painand emotional symptoms associated with depression in a new,eight-week, placebo-controlled study of 327 adult patients with atleast moderate pain and major depression. The results werepresented today at the 15th European Congress of Psychiatry (AEP)in Madrid,...